Renin-angiotensin system in the brain as a new target of antihypertensive therapy

Hypertension Research

Volumn 31, Issue 8, 2008, Pages 1487-1488

  Ito, Satoru ^a   Komatsu, Kazutoshi ^a   Yajima, Yoshiharu ^a   Hirayama, Atsushi ^a  

^a NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Angiotensin II type 1 receptor; Blood pressure; Renin angiotensin system of the brain; Rostral ventrolateral medulla; Sympathetic nerve activity

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANGIOTENSIN II; ANTIHYPERTENSIVE AGENT; SODIUM CHLORIDE;

ADRENERGIC ACTIVITY; ALZHEIMER DISEASE; ANTIHYPERTENSIVE ACTIVITY; BLOOD PRESSURE REGULATION; CARDIOVASCULAR RISK; COGNITIVE DEFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG TARGETING; EDITORIAL; ESSENTIAL HYPERTENSION; HORMONE ACTION; HUMAN; HYPERTENSION; HYPOTHALAMUS; INSULIN RESISTANCE; MEDULLA OBLONGATA; OBESITY; OXIDATIVE STRESS; PRESYNAPTIC NERVE; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; THALAMUS VENTRAL NUCLEUS;

EID: 55449084867     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1291/hypres.31.1487     Document Type: Editorial

References (9)

1. Sasaki S, Dampney RAL: Tonic cardiovascular effects of angiotensin II in the ventrolateral medulla. Hypertension 1990; 15: 274-283.
2. Muratani H, Averill DB, Ferrario CM: Effect of angiotensin II in ventrolaterall medulla of spontaneously hypertensive rats. Am J Physiol 1991; 260: R977-R984.
3. Ito S, Komatsu K, Tsukamoto K, Kanmatsuse K, Sved AF: Ventrolateral medulla AT1 receptors support blood pressure in hypertensive rats. Hypertension 2002; 40: 552-559.
4. Ito S, Komatsu K, Tsukamoto K, Kanmatsuse K, Sved AF: Ventrolateral medulla AT1 receptors support arterial pressure in Dahl salt-sensitive rats. Hypertension 2003; 41: 744-750.
5. Saxby BK, Harrington F, Wesnes KA, McKeith IG, Ford GA: Candesartan and cognitive decline in older patients with hypertension: a substudy of the SCOPE trial. Neurology 2008; 70: 1858-1866.
6. Wang J, Ho L, Chen L, et al: Valsartan lowers brain beta-amyloid protein levels and improves spatial learning in a mouse model of Alzheimer disease. J Clin Invest 2007; 117: 3393-3402.
7. Solomon SD, Wang D, Finn P, et al: Effect of candesartan on cause-specific mortality in heart failure patients: the Candesartan in Heart failure Assessment of Reduction in Mortality and morbidity (CHARM) program. Circulation 2004; 110: 2180-2183.
8. Mochizuki S, Dahlöf B, Shimizu M, et al, Jikei Heart Study Group: Valsartan in a Japanese population with hypertension and other cardiovascular disease (Jikei Heart Study): a randomised, open-label, blinded endpoint morbidity-mortality study. Lancet 2007; 369: 1431-1439.
9. Oshima N, Kumagai H, Onimaru H, et al: Monosynaptic excitatory connection from the rostral ventrolateral medulla to sympathetic preganglionic neurons revealed by simultaneous recordings. Hypertens Res 2008; 31: 1445-1454.